#mitHerz-Podcast: Die Cholesterin-Lüge! Was ist Mythos? Was ist Realität? | Kooperatives Herzzentrum Köln

Folge 1 vom #mitHerz-Podcast vom kooperativen Herzzentrum
beidseits des Rheins in Köln - mit den Kardiologen Hanno Wied,
Dr. Dennis Rottländer und mit Lars Göllnitz. Medizin,
Menschliches und Mehrwert fürs Herz.





--


Das Kooperative Herzzentrum bei Instagram


Das Kooperative Herzzentrum bei Facebook


Das Kooperative Herzzentrum bei YouTube


Das Kooperative Herzzentrum bei LinkedIn


--


Im Podcast erwähnte Links:


https://programm.ard.de/TV/arte/cholesterin--der-gro-e-bluff/eid_287242170031373


https://herzstiftung.de/ihre-herzgesundheit/gesund-bleiben/ernaehrung/kochbuch





Verzeichnis der in diesem Podcast genutzten Studien und Quellen:


Navarese et. al., Association Between Baseline LDL-C Level and
Total and Cardiovascular Mortality After LDL-C Lowering
JAMA. 2018 Apr 17; 319(15): 1566–1579


Ference et al, Low-density lipoproteins cause atherosclerotic
cardiovascular disease. 1. Evidence from genetic, epidemiologic,
and clinical studies. A consensus statement from the European
Atherosclerosis Society Consensus Panel, European Heart Journal
(2017) 38, 2459–2472 CURRENT OPINION doi:10.1093/eurheartj/ehx144


Toth et. al, Long-term statin persistence is poor among high-risk
patients with dyslipidemia: a real-world administrative claims
analysis, Lipids Health Dis. 2019; 18: 175. Published online
2019 Sep 16. doi: 10.1186/s12944-019-1099-z


Nielsen et al, Negative statin-related news stories decrease
statin persistence and increase myocardial infarction and
cardiovascular mortality: a nationwide prospective cohort study,
Eur Heart J 2016 Mar 14;37(11):908-916. doi:
10.1093/eurheartj/ehv641. Epub 2015 Dec 1


Vortrag «Dislipidemia» von Dr. med. Manuela Schöb am 21st
PostADA/PostENDO-Symposium in Bern am 1. September 2022 in Bern
Renate Bonifer, LDL-C-Zielwerte, Nebenwirkungen und neue
Substanzen


Benito-Vicente et. al Familial Hypercholesterolemia: The Most
Frequent Cholesterol Metabolism Disorder Caused Disease, Int. J.
Mol. Sci. 2018, 19(11),
3426; https://doi.org/10.3390/ijms19113426


Mach et. al, 2019 Guidelines on Dyslipidaemias (Management of)
ESC Clinical Practice Guidelines, European Heart Journal, Volume
41, Issue 1, 1 January 2020, Pages 111
188, https://doi.org/10.1093/eurheartj/ehz455


Cholesterol Treatment Trialists’ Collaboration, Effect of statin
therapy on muscle symptoms: an individual participant data
meta-analysis of large-scale, randomised, double-blind trials,
Lancet 2022 Sep 10;400(10355):832-845. doi:
10.1016/S0140-6736(22)01545-8. Epub 2022 Aug 29.


Trompet et. al., Pravastatin and cognitive function in the
elderly. Results of the PROSPER study, J Neurol 2010
Jan;257(1):85-90. doi: 10.1007/s00415-009-5271-7. Epub 2009
Aug 4


https://de.wikipedia.org/wiki/Arzneimittelzulassung